Family Care Hospitals Ltd
Incorporated in 1994, Family Care Hospitals
Ltd is in the business of Healthcare Services[1]
- Market Cap ₹ 22.1 Cr.
- Current Price ₹ 4.09
- High / Low ₹ 9.50 / 3.40
- Stock P/E 0.75
- Book Value ₹ 2.49
- Dividend Yield 0.00 %
- ROCE 77.2 %
- ROE 84.8 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%
- Debtor days have improved from 219 to 93.3 days.
Cons
- The company has delivered a poor sales growth of -9.83% over past five years.
- Promoter holding is low: 18.5%
- Tax rate seems low
- Promoters have pledged or encumbered 61.7% of their holding.
- Promoter holding has decreased over last 3 years: -23.8%
- Working capital days have increased from 269 days to 402 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | 1 | 2 | 5 | 14 | 13 | 35 | 42 | 42 | 40 | 8 | 4 | |
0 | 0 | 1 | 2 | 4 | 13 | 11 | 27 | 33 | 34 | 33 | -21 | -24 | |
Operating Profit | -0 | -0 | 0 | 0 | 1 | 1 | 2 | 8 | 9 | 8 | 7 | 28 | 28 |
OPM % | -3,400% | -243% | 20% | 14% | 26% | 10% | 17% | 23% | 21% | 20% | 17% | 360% | 704% |
0 | -25 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 1 | 3 | -71 | -72 | |
Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit before tax | -0 | -25 | 0 | 0 | 1 | 0 | 0 | 6 | 7 | 7 | 8 | -44 | -45 |
Tax % | 0% | 0% | 0% | 21% | 20% | 60% | 33% | 28% | 26% | 29% | -54% | -1% | |
-0 | -25 | 0 | 0 | 1 | 0 | 0 | 4 | 5 | 5 | 13 | -44 | -45 | |
EPS in Rs | -3.41 | 0.00 | 0.02 | 0.12 | 0.00 | 0.00 | 0.56 | 0.71 | 0.97 | 2.32 | -8.17 | -8.35 | |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 6% | 5% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 60% |
5 Years: | -10% |
3 Years: | -43% |
TTM: | -88% |
Compounded Profit Growth | |
---|---|
10 Years: | 79% |
5 Years: | 186% |
3 Years: | 80% |
TTM: | 164% |
Stock Price CAGR | |
---|---|
10 Years: | -2% |
5 Years: | -11% |
3 Years: | -41% |
1 Year: | -46% |
Return on Equity | |
---|---|
10 Years: | 37% |
5 Years: | 42% |
3 Years: | 41% |
Last Year: | 85% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 54 | 54 | 54 |
Reserves | -3 | -28 | -28 | -28 | -27 | -27 | -27 | -23 | -18 | -8 | 4 | -41 |
0 | 1 | 1 | 0 | 0 | 6 | 10 | 6 | 4 | 4 | 4 | 3 | |
0 | 0 | 0 | 1 | 5 | 3 | 3 | 6 | 21 | 24 | 8 | 29 | |
Total Liabilities | 0 | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 75 | 70 | 46 |
0 | 2 | 2 | 2 | 7 | 9 | 10 | 8 | 7 | 7 | 6 | 4 | |
CWIP | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | 3 | 3 | 2 | 2 | 5 | 8 | 12 | 33 | 68 | 64 | 42 | |
Total Assets | 0 | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 75 | 70 | 46 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0 | -0 | 0 | 0 | 3 | -4 | -1 | 4 | 2 | -5 | -0 | -17 | |
0 | -2 | -0 | -1 | -5 | -2 | -2 | -0 | -0 | -2 | -0 | 1 | |
0 | 5 | 0 | 1 | 0 | 6 | 5 | -5 | -2 | 26 | -1 | -1 | |
Net Cash Flow | 0 | 3 | -0 | -0 | -2 | 0 | 1 | -1 | -0 | 19 | -2 | -17 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 0 | 0 | 0 | 0 | 65 | 113 | 93 | 186 | 252 | 310 | 93 |
Inventory Days | 149 | 29 | 4 | 6 | 16 | |||||||
Days Payable | 977 | 212 | 382 | 387 | 126 | |||||||
Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 65 | -715 | -89 | -193 | -129 | 201 | 93 |
Working Capital Days | -14,600 | -2,920 | -160 | -272 | -312 | -146 | -16 | 55 | 100 | 149 | 255 | 402 |
ROCE % | -2,267% | -4% | 1% | 5% | 25% | 7% | 8% | 47% | 46% | 23% | 15% | 77% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Aug - Newspaper Publication of Financial Result for Quarter ended 30 June 2025
-
Announcement Under Regulation 30 - Reconstitution Of Committees
5 Aug - Board committees reconstituted with specified members effective 5 August 2025.
- Unaudited Finacial Result For Quarter Ended 30 June 2025 5 Aug
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 05.08.2025
5 Aug - Q1 FY2026 un-audited results approved; board committees reconstituted on 5 Aug 2025.
-
Board Meeting Intimation for Board Meeting Intimation For To Consider And Approve Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2025.
30 Jul - Board meeting on 5 Aug to approve Q1 June 2025 un-audited financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1][2][3]
a) Dental:
Company provides 3D imaging in Cone
Beam Computed Tomography (CBCT),
a useful tool for imaging the craniofacial
area and in 2D Imaging it provides Digital Orthopantomogram (OPG), and Lateral Cephalogram.
b) ENT:
Company offers high quality images
to view the hard tissues within the ear
canal with a wide range of 'Field of View'
(FOV).
c) Radiographic Reports:
All 3D and 2D images are interpreted
and reported by experienced maxillo
facial radiologists of company
d) Family Care Hospitals:
Company has 2 hospitals, one in Mira
Road, Maharashtra and the other at Mahim, Mumbai both of which provide General Surgeries, Plastic Surgeries and treatment in Gynecology, Cardiology, Proctology, Urology, Orthopedics
and ENT.